Compare IDE & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IDE | SXTC |
|---|---|---|
| Founded | 2010 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.1M | 177.7M |
| IPO Year | N/A | 2019 |
| Metric | IDE | SXTC |
|---|---|---|
| Price | $13.87 | $2.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 33.5K | ★ 697.1K |
| Earning Date | 01-01-0001 | 08-19-2019 |
| Dividend Yield | ★ 8.83% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,537,987.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.61 | $2.34 |
| 52 Week High | $10.46 | $1,175.99 |
| Indicator | IDE | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 80.00 | 59.84 |
| Support Level | $13.23 | $2.34 |
| Resistance Level | $13.52 | $6.40 |
| Average True Range (ATR) | 0.15 | 0.42 |
| MACD | 0.01 | 0.24 |
| Stochastic Oscillator | 87.39 | 39.18 |
Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.